Letter: sequential or combined systemic treatment for unresectable hepatocellular carcinoma-authors' reply

被引：0
|
作者：
Kirstein, Martha M. [1 ,2 ]
Scheiner, Bernhard [3 ]
Pinter, Matthias [3 ]
Vogel, Arndt [1 ]
机构：
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[2] Univ Med Ctr Schleswig Holstein, Dept Med 1, Lubeck, Germany
[3] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2020年 / 52卷 / 05期
关键词：
SORAFENIB;
D O I：
10.1111/apt.15980
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Kirstein et al and Mo et al papers. To view these articles, visit and
引用
收藏
页码：917 / 918
页数：2
相关论文
共 50 条
  • [31] Letter: pyogenic liver abscess is a red flag sign of hepatocellular carcinoma - authors' reply
    Kao, W-Y
    Su, C-W
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (09) : 906 - 907
  • [32] Letter: innovative use of the alfapump system to treat small hepatocellular carcinoma - authors' reply
    Stirnimann, G.
    De Gottardi, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) : 696 - 697
  • [33] Modeling sequential systemic therapy for unresectable hepatocellular carcinoma in the era of immunotherapy: What comes next?
    Celsa, Ciro
    Cabibbo, Giuseppe
    Enea, Marco
    Battaglia, Salvatore
    Rizzo, Giacomo Emanuele Maria
    Camma, Calogero
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [34] The Impact of Sequential Therapies after First-Line Systemic Therapies in Unresectable Hepatocellular Carcinoma
    Lee, Shou-Wu
    Lee, Teng-Yu
    Yang, Sheng-Shun
    Huang, Yi-Jie
    Peng, Yen-Chun
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [35] Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma
    Jaeger, HJ
    Mehring, UM
    Castaneda, F
    Hasse, F
    Blumhardt, G
    Loehlein, D
    Mathias, KD
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1996, 19 (06) : 388 - 396
  • [36] Selection of Systemic Treatment Regimen for Unresectable Hepatocellular Carcinoma: Does Etiology Matter?
    Kudo, Masatoshi
    LIVER CANCER, 2022, 11 (04) : 283 - 289
  • [37] Treatment Induced Changes in Systemic Immune Environment in Patients with Unresectable Hepatocellular Carcinoma
    Zhao, C.
    Chiang, C. L.
    Chen, W.
    Danyang, Z.
    Kong, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E185 - E185
  • [38] Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease. Authors' reply
    Vilar-Gomez, Eduardo
    Chalasani, Naga
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (07) : 836 - 837
  • [39] Regorafenib for the treatment of unresectable hepatocellular carcinoma
    Rimassa, Lorenza
    Pressiani, Tiziana
    Personeni, Nicola
    Santoro, Armando
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (07) : 567 - 576
  • [40] Interventional treatment for unresectable hepatocellular carcinoma
    Satoru Murata
    Takahiko Mine
    Fumie Sugihara
    Daisuke Yasui
    Hidenori Yamaguchi
    Tatsuo Ueda
    Shiro Onozawa
    Shin-ichiro Kumita
    World Journal of Gastroenterology, 2014, (37) : 13453 - 13465
12345